Craft
  • Home
  •  / Odyssey Therapeutics
Odyssey Therapeutics

Odyssey Therapeutics

Total Funding

$386 M

Odyssey Therapeutics Summary

Company summary

Overview
Odyssey Therapeutics is a biotechnology company. It develops inflammation and oncology medicines for patients with cancer and inflammatory diseases.
Type
Private
Status
Active
Founded
2018
HQ
Cambridge, MA, US | view all locations
Website
https://odysseytx.com
Cybersecurity rating
Sectors

Key people

  • Gary D. Glick

    Gary D. Glick, Founder, Chief Executive Officer

  • Natalie Dales

    Natalie Dales, Senior Vice President

  • Joseph McDonald

    Joseph McDonald, Chief Data Officer

  • Tony Opipari, Senior Vice President, Translational Medicine

    LocationsView all

    3 locations detected

    • Cambridge, MA HQ

      United States

      301 Binney St

    • Ann Arbor, MI

      United States

      1350 Highland Dr a

    • Frankfurt am Main, HE

      Germany

      Brüningstraße 50

    Footer menu